Hypoxic Red Blood Cells in Sickle Cell Anemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Biree Andemariam, MD
New England Sickle Cell Institute, University of Connecticut
Principal Investigator - Enrico Novelli, MD, MS
University of Pittsburgh Medical Center
Principal Investigator - Laurel Omert, MD, FACS
Hemanext Inc.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- New England Sickle Cell Institute, University of Connecticut
Farmington, Connecticut, United States
Biree Andemariam, MD - Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
Cassandra Josephson, MD - Emory University School of Medicine
Atlanta, Georgia, United States
Ross Fasano, MD - John Hopkins University School of Medicine
Baltimore, Maryland, United States
Elizabeth Crowe, MD, PhD - University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Alesia Kaplan, MD - University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Enrico Novelli, MD, MS
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2026
- Primary completion
- 30 Apr 2028
- Completion
- 30 Sept 2028
- Last update posted
- 7 Jan 2026
- Registered enrollment
- 48
- Registry id
- NCT06743113
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.